|
|
||||||||
a Quality Biological, Inc., Gaithersburg, Maryland, USA;
b The Armed Forces Radiobiology Research Institute, Bethesda, Maryland, USA
Key Words. Stem cell • Serum-free culture • Ex vivo expansion • Transplantation • Progenitor cells
Correspondence:
Dr. Ronald L. Brown, Quality Biological, Inc., 7581 Lindbergh Drive, Gaithersburg, MD 20879, USA.
The goal of ex vivo culture is to expand and/or differentiate cells in culture such that they retain their functional characteristics when reinfused into a patient. The studies presented here analyzed the use of culture conditions devoid of serum to expand murine hematopoietic stem cells. Bone marrow cells from male B6D2F1/J mice were cultured for up to 28 days in serum-free medium in the absence or presence of stem cell factor (SCF), GM-CSF or a combination of the two factors. Cells cultured for up to 21 days were assessed for granulocyte-macrophage colony-forming cells (GM-CFC), spleen colony-forming units, and cells responsible for short-term and long-term hematopoietic repopulation in lethally irradiated mice. Compared to initial seeding levels, the presence of SCF and GM-CSF increased total cell numbers 90-fold and GM-CFC numbers 42-fold over a 21-28 day culture period. Although spleen colony-forming unit cells did not increase, they were maintained at initial seeding levels over a 21-day period in the presence of SCF and GM-CSF. In lethally irradiated mice, survival enhancement and hematologic reconstitution were optimum with cells cultured for only seven days: survival at six months was 100% with cells cultured in SCF plus GM-CSF or SCF alone, compared to 50% with cells cultured with only GM-CSF. Hybridization analysis of bone marrow, spleen and thymus DNA from irradiated mice transplanted with these cultured cells confirmed male donor cell-derived repopulation at 45 days and 180 days post-transplant. These studies illustrate that murine GM-CFC can be expanded and that long-term repopulating hematopoietic cells can, at the minimum, be maintained ex vivo in serum-free culture. The use of defined serum-free culture systems holds great promise for further evaluation of the mechanisms that control hematopoietic stem cell proliferation.
This article has been cited by other articles:
![]() |
A. B. Deisseroth Clinical Trials Involving Multidrug Resistance Transcription Units in Retroviral Vectors Clin. Cancer Res., July 1, 1999; 5(7): 1607 - 1609. [Full Text] [PDF] |
||||
![]() |
D. Möbest, S.-R. Goan, I. Junghahn, J. Winkler, I. Fichtner, M. Becker, E. de Lima-Hahn, R. Mertelsmann, and R. Henschler Differential Kinetics of Primitive Hematopoietic Cells Assayed In Vitro and In Vivo During Serum-Free Suspension Culture of CD34+ Blood Progenitor Cells Stem Cells, May 1, 1999; 17(3): 152 - 161. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |